Home/Filings/4/0001437749-22-009651
4//SEC Filing

Tucker Sean 4

Accession 0001437749-22-009651

CIK 0000072444other

Filed

Apr 24, 8:00 PM ET

Accepted

Apr 25, 4:40 PM ET

Size

8.2 KB

Accession

0001437749-22-009651

Insider Transaction Report

Form 4
Period: 2022-04-22
Tucker Sean
SVP, Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2022-04-2240,00084,061 total
    Exercise: $0.77Exp: 2029-05-11Common Stock (40,000 underlying)
  • Exercise/Conversion

    Common Stock

    2022-04-22$0.77/sh+40,000$30,800127,631 total
Holdings
  • Common Stock

    (indirect: By joint tenancy with Frances Chang and Sean Tucker)
    51,465
  • Common Stock

    (indirect: By Spouse)
    9,060
Footnotes (1)
  • [F1]The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of May 10, 2019, and the remaining shares in 36 equal monthly installments thereafter.

Issuer

Vaxart, Inc.

CIK 0000072444

Entity typeother

Related Parties

1
  • filerCIK 0001652204

Filing Metadata

Form type
4
Filed
Apr 24, 8:00 PM ET
Accepted
Apr 25, 4:40 PM ET
Size
8.2 KB